Other Liabilities (Details) $ / shares in Units, $ in Thousands |
1 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Sep. 30, 2018
item
$ / shares
shares
|
Dec. 31, 2019
USD ($)
$ / shares
|
Dec. 31, 2018
$ / shares
|
Dec. 31, 2017
$ / shares
|
Dec. 31, 2016
$ / shares
|
|
Other Liabilities | |||||
Exercise price | $ 1.00 | $ 1.00 | $ 0.97 | $ 1.02 | |
Warrants | |||||
Other Liabilities | |||||
Number of securities called by each warrant | shares | 0.5 | ||||
Warrants sold | shares | 13,062,878 | ||||
Sale price (per warrant) | $ 0.01 | ||||
Exercise price | 1.00 | ||||
Gain on revaluation of liability | $ | $ 524 | ||||
Initial warrant liability (per share) | $ 2.212 | ||||
Number of warrants redeemable shares | item | 2 | ||||
Minimum | Expected Volatility | |||||
Other Liabilities | |||||
Measurement input | 52.0 | ||||
Minimum | Risk Free Interest Rate | |||||
Other Liabilities | |||||
Measurement input | 1.5 | ||||
Maximum | Expected Volatility | |||||
Other Liabilities | |||||
Measurement input | 61.5 | ||||
Maximum | Risk Free Interest Rate | |||||
Other Liabilities | |||||
Measurement input | 1.7 |
X | ||||||||||
- Definition Per share amount received by the Company on sale of warrants. No definition available.
|
X | ||||||||||
- Definition The number of warrants or rights issued during the period. No definition available.
|
X | ||||||||||
- Definition Number of warrants redeemable for each common share No definition available.
|
X | ||||||||||
- Definition The value of warrant liability per share. No definition available.
|
X | ||||||||||
- Definition Value of input used to measure alternative investment. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. No definition available.
|
X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|